NORCO — Class III drug recall D-0413-2018
Terminated recall by ALLERGAN, reported 2018-02-21, distributed nationwide. Labeling: Not Elsewhere Classified: does not have the required "CII" controlled drug classification indication
| Recall number | D-0413-2018 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | ALLERGAN, Madison, NJ, United States |
| Recall initiated | 2018-02-02 |
| Classified | 2018-02-09 |
| Reported by FDA | 2018-02-21 |
| Terminated | 2019-02-07 |
| Distributed | Nationwide (US) |
| Quantity | 8 bottles |
| Reason classes | labeling |
| NDC | 00023-6022-01 |
| Lot numbers | 07/19, 544821A |
Product
NORCO (Hydrocodone Bitartrate and Acetaminophen) Tablets, USP, 10 mg/325 mg, 100-count bottles, Rx Only, Distributed by: Allergan USA, Inc., Irvine, CA 92612, NDC 0023-6022-01.
Reason for recall
Labeling: Not Elsewhere Classified: does not have the required "CII" controlled drug classification indication on the primary label.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0413-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.